Effect of Gram Stain–Guided Initial Antibiotic Therapy on Clinical Response in Patients With Ventilator-Associated Pneumonia

  12 April 2022

Does Gram stain–guided antibiotic therapy restrict the administration of broad-spectrum antibiotic agents for ventilator-associated pneumonia without detrimental effects on patient outcomes?

In this randomized clinical trial that included 206 patients with ventilator-associated pneumonia in the intensive care unit, the clinical response to Gram stain–guided antibiotic therapy was noninferior to that of guideline-based antibiotic therapy (76.7% vs 71.8%). Gram stain–guided antibiotic therapy reduced the use of antipseudomonal agents and anti–methicillin-resistant Staphylococcus aureus agents.

The findings of this trial suggest that Gram staining can be used in the critical care setting to ameliorate the spread of multidrug-resistant pathogens.

Further reading: JAMA Network Open
Author(s): Jumpei Yoshimura et al
Healthy Patients  


Unrestricted financial support by:

Antimicrobial Resistance Fighter Coalition


JSS University


Technology Database

Display your AMR Technology, Product and Service

Suppliers and Users of Technologies, Products and Services benefit from CAPI.
CAPI (Continuous AMR Partnering Initiative) unites Suppliers and Users worldwide with the aim to add to the curbing of AMR.

Read more and make your own Technology Page >>
What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!